Extrawell Pharmaceutical Holdings Limited

HKEX:0858.HK

0.033 (HKD) • At close September 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999
Revenue 59.09872.57773.92578.80277.58489.21885.762107.903142.201128.833150.673151.068157.406198.816196.291184.434165.079158.763178.265169.766215.631215.523199.499135.159126.978
Cost of Revenue 30.31941.43436.36936.23634.66839.61843.71364.00772.88877.776110.512104.374109.943146.785142.447126.547113.004109.996108.45123.676135.076118.313113.74373.74385.102
Gross Profit 28.77931.14337.55642.56642.91649.642.04943.89669.31351.05740.16146.69447.46352.03153.84457.88752.07548.76769.81546.0980.55597.2185.75661.41641.876
Gross Profit Ratio 0.4870.4290.5080.540.5530.5560.490.4070.4870.3960.2670.3090.3020.2620.2740.3140.3150.3070.3920.2710.3740.4510.430.4540.33
Reseach & Development Expenses 0.1940.8810.4440000001.6134.0843.2514.8858.33900000000000
General & Administrative Expenses 22.15825.73824.20623.8926.44526.40227.00727.23126.46829.31534.15127.88827.2329.41828.42130.59635.29526.65636.07629.43632.76728.46724.70423.45214.014
Selling & Marketing Expenses 13.17516.68326.29229.54424.55240.1732.25931.67342.35936.20715.429.51610.4316.48120.64523.18816.32414.43614.8917.04618.81617.78313.58810.02212.904
SG&A 36.94141.41655.5749.55159.24966.57259.26658.90468.82765.52249.57137.40437.6645.89949.06653.78451.61941.09250.96646.48251.58346.2538.29233.47426.918
Other Expenses 0.4140.4370.20900.002002.8730.2280.2220.2240.222-3.561-11.592-13.518-6.676-2.1018.68815.89486.40885.37214.9131.484.3240.987
Operating Expenses 36.94142.29756.01449.55159.24911.6496.61596.538103.77579.63951.65536.65938.98442.64635.54847.10849.51849.7866.86132.89136.95561.16339.77237.79827.905
Operating Income -8.162-11.154-18.458-6.985-16.333-16.972-17.217-15.0080.486-48.20837.78911.9728.4795.10312.7887.9912.5579.57.605-85.632-31.73357.35651.59227.20817.707
Operating Income Ratio -0.138-0.154-0.25-0.089-0.211-0.19-0.201-0.1390.003-0.3740.2510.0790.0540.0260.0650.0430.0150.060.043-0.504-0.1470.2660.2590.2010.139
Total Other Income Expenses Net -149.072145.904154.441-109.799101.82480.34646.40333.93527.004-23.56442.39-1.1498.384-4.282-5.508-2.79-0.16410.3163.742-1.03520.56517.5963.0781.8242.142
Income Before Tax -157.234134.75135.983-116.78485.49163.37429.18618.92727.49-52.14630.8968.88616.8635.10312.7887.9892.3939.3036.697-87.835-35.83553.64349.06225.44216.113
Income Before Tax Ratio -2.6611.8571.839-1.4821.1020.710.340.1750.193-0.4050.2050.0590.1070.0260.0650.0430.0140.0590.038-0.517-0.1660.2490.2460.1880.127
Income Tax Expense 2.1311.1281.2394.314-0.090.050.0860.6160.090.09214.5370.7060.9261.055-2.784-9.41815.7280.3692.51-1.7931.1030.9143.8823.3131.988
Net Income -162.949129.265130.588-121.09883.2864.0329.9320.79627.4565.45715.710.87620.41411.56714.62415.551-13.3358.9344.187-75.82314.64146.68942.00220.5414.043
Net Income Ratio -2.7571.7811.766-1.5371.0730.7180.3490.1930.1934.3890.1040.0720.130.0580.0750.084-0.0810.0560.023-0.4470.0680.2170.2110.1520.111
EPS -0.0680.0540.055-0.0510.0350.020.0090.0090.0140.240.0060.0070.0090.0050.0060.007-0.0060.0040.002-0.0330.0060.0210.0220.0110.007
EPS Diluted -0.0680.0440.044-0.0510.0280.020.0090.0080.0110.240.0050.0070.0090.0050.0060.007-0.0060.0040.002-0.0330.0060.0210.0220.0110.007
EBITDA 0.751-2.489-9.8261.08-10.031-10.676-10.83-8.5226.7816.039-6.28213.12412.54517.50424.01319.7247.7924.2778.778-69.561-31.82453.11645.98423.61813.971
EBITDA Ratio 0.013-0.034-0.1330.014-0.129-0.12-0.126-0.0790.0480.124-0.0420.0870.080.0880.1220.1070.0470.0270.049-0.41-0.1480.2460.230.1750.11